ULURU Releases Altrazeal 0.75-g Blister Pack in U.S.

The pharmaceutical packaging and product are intended to give medical staff a convenient option for treatment of small, chronic wounds.

ULURU Inc. (OTCQB: ULUR) announced today the availability in the U.S. market of Altrazeal® in an innovative 0.75 gram blister pack.The development of this innovative packaging system was in response to requests from wound care practitioners. This packaging configuration overcomes the concerns expressed by users, including excessive waste of product, inability to see the product during application and unit cost for the treatment of small chronic wounds.

No votes yet
Syndicate content